Skip to main content

Advertisement

Correction to: Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer

Article metrics

  • 61 Accesses

The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:282

Correction to: J Exp Clin Cancer Res (2018) 37: 282

https://doi.org/10.1186/s13046-018-0960-7

In the original publication of this article [1], Fig. 3 is wrong, but does not affect discussions and conclusions drawn in the article.

The corrected Fig. 3 is shown below:

Fig. 3
figure1

.

Reference

  1. 1.

    Yao Y, et al. Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer. J Exp Clin Cancer Res. 2018;37:282. https://doi.org/10.1186/s13046-018-0960-7.

Download references

Author information

Correspondence to Na Lu.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yao, Y., Guo, Q., Cao, Y. et al. Correction to: Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer. J Exp Clin Cancer Res 38, 451 (2019) doi:10.1186/s13046-019-1441-3

Download citation